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Abstract: Critical care units are equipped with commercial monitoring devices capable of
sensing patients’ physiological parameters and supervising the achievement of the established
therapeutic goals. This avoids human errors in this task and considerably decreases the work-
load of the healthcare staff. However, at present there still is a very relevant physiological
parameter that is measured and supervised manually by the critical care units’ healthcare
staff: urine output. This paper presents a patent-pending device capable of automatically
recording and supervising the urine output of a critical care patient. A high precision scale
is used to measure the weight of a commercial urine meter. On the scale’s pan there is a
support frame made up of Bosch proﬁles that isolates the scale from force transmission from
the patient’s bed, and guarantees that the urine ﬂows properly through the urine meter input
tube. The scale’s readings are sent to a PC via Bluetooth where an application supervises the
achievement of the therapeutic goals. The device is currently undergoing tests at a research
unit associated with the University Hospital of Getafe in Spain.
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1. Introduction
Current criticalcare unitsareequippedwithmodernandsophisticatedcommercialmonitoringdevices
that are capable of sensing most of the patient’s physiological parameters. Heart rate, blood pressure,
blood levels of oxygen saturation, respiratory rate, brain waves, and intracranial pressure are just a few
examples. They provide physicians with an electronic recording of physiological parameters that can
be inspected at any time. Most of these monitoring devices also allow physicians to establish thera-
peutic goals for the parameters they record. The fulﬁllment of these therapeutic goals is automatically
supervised and, if a violation occurs, the devices generate audible warnings to alert the health care
staff [1, 2, 3].
The overall result is a considerable reduction in the workload of the healthcare staff, since they do not
need to continuously supervise the physiological parameters of each of the patients of the critical care
unit. Furthermore, as with any repetitive and monotonous task, supervision of the temporal evolution of
the patient’s physiological parameters is prone to errors [2, 4]. Many of these errors are avoided when
such tasks are automated.
Arguably, the most relevant physiological parameter that is still measured and supervised manually
by critical care unit staff is urine output (UO). This parameter is the best real-time indicator of the state
of the patient’s kidneys. If a kidney is producing an adequate amount of urine it means that it is well
perfused and oxygenated. An inadequateamount indicates that thepatient is affected by somepathology.
When the UO ofa patient is too low, the patient is said to haveoliguria. If the patient does not produce
urine at all, then he/she is said to have anuria. The most common pathophysiologic mechanisms causing
oliguria and anuria are (1) prerenal azotemia which can be the result of heart failure, infectious diseases
and gastrointestinaldiseases; (2) intrinsickidney damage, which can be caused by acute tubularnecrosis,
rhabdomyolysis, medication and/or glomerulonephritis; and (3) postrenal azotemia by obstruction of the
urine ﬂow which can be caused by an enlarged prostate, compression of the urethra by a tumor, an
expanding hematoma or ﬂuid collection [5]. Sometimes, UO can be too high; in these cases the patient
is said to have polyuria. Diabetes is widely recognized as the most common cause of polyuria [6].
Urine output is also essential for calculating the patient’s water balance; and is used in multiple
therapeutic protocols to assess the reaction of the patient to the treatment. Two of the more prominent
clinicalalgorithmswhereUO playsacentralrolearetheresuscitationofsepticshockpatients[7], and the
resuscitationandearlymanagementofburnpatients[8]. Inthelatter, whiletheendpointsofresuscitation
are debatable, hourly UO is a well-established parameter in the ﬂuid management of these patients, as
well as one of the most reliable assessments of the patient’s state and evolution. In the case of the septic
shock patient resuscitation, achieving a certain minimum value for the UO itself is a therapeutic goal.
To measure the patient’s UO, a Foley catheter is introduced through the patient’s urethra until it
reaches his/her bladder. The other end of the catheter is connected to a ﬂexible plastic tube which is
connected to a graduated container where the urine is collected. Every hour the nursing staff manually
records the reading of the container of each patient, and operates a valve which releases the urine into
a larger container (see Figure 1). Therefore, the healthcare staff does not beneﬁt from the advantages
of having a digital recording of this physiological parameter, or of the automatic supervision of its
therapeutic goals. A device capable of automatically measuring the patients’ UO, and supervising theSensors 2010, 10 936
attainment of the established therapeutic goals, would release the healthcare staff from a considerable
amount of work, and would permit measurements to be carried out more frequently.
Figure 1. Commercial urine meter used in critical care units.
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This paper presents a patent-pending device [9] capable of recording and supervising the UO of
critically ill patients. Section 2 explains the challenges of automating the sensing of UO, reviews brieﬂy
previous attempts to solve this problem, and describes the constraints that have guided the design of
the sensor presented in this paper. Section 3 presents this sensor, the algorithms employed to supervise
the therapeutic goals established for UO, and the results of a set of experiments that have allowed us to
estimate the accuracy of the sensor’s measurements. Section 4 shows some preliminary results obtained
with our device, and section 5 discusses this work. Finally, a series of conclusions and lines of future
extension are given.
2. Automatic Sensing of Patient’s Urine Output
In the design of a sensor for measuring UO several considerations must be taken into account. On
the one hand, any component of the sensor that is in contact, or may be in contact, with the urine of
the patient cannot be reused for different patients. Furthermore, current commercial urinemeters usually
need to be changed approximately every 4-7 days for hygienic reasons. Therefore, any component of
the sensor that is or may be in contact with the urine must be easy to dispose of, and should have a
low price.
Contact with urine also means that the component is in indirect contact with the patient’s bladder
through the Foley catheter. Therefore, the components that are in contact or may enter into contact with
the urine have to be sterilized before use.Sensors 2010, 10 937
Urine usually is acidic, although sometimes it can be slightly basic —its pH varies between 4.5 and 8.
It usually contains uric acid (25–75 mg/L), urea (15–34 g/24 h), sodium (130–260 mEq/24 h), potassium
(less than 90 mEq/24 h), chlorine (110–250 mEq/24 h), and Copper (less than 30 mcg/24 h), among
other components [5]. Thus, it can be corrosive, especially for metals.
A sensor which aims to automatically measure UO must be able to provide feedback on urine pro-
duction at least every hour, in order to generate similar information to that produced manually by the
nursing staff. However, providing feedback at shorter intervals would be desirable. When a patient is
producing a small amount of urine, it is more important to measure these quantities accurately. If the
patient is producing a normal amount, the accuracy can be relaxed. Usually, the more urine a patient
produces, the less relevant it is to have a highly accurate measurement.
Given the lack of sensors for measuring patients’ UO, there are no guidelines that specify the accu-
racy that they should provide, nor any consensus on what is an acceptable error when measuring this
parameter. Before designing our sensor, we asked the medical team that collaborates with us to de-
ﬁne, according to their criteria, what the accuracy requirements for this type of sensor should be. They
provided the following requirements: The measurement error must not exceed
• 3 mL/h when the hourly UO is less than 40 mL/h
• 5 mL/h when the hourly UO is between 40 mL/h and 100 mL/h
• 10 mL/h when the hourly UO is between 100 mL/h and 250 mL/h
• 20 mL/h when the hourly UO is between 250 mL/h and 500 mL/h
• 40 mL/h when the hourly UO is over 500 mL/h.
Due to the lack of any other criteria, these are the ones we considered in the design of our sensor.
2.1. Previous Work
Ultrasound sensors have been proposed for use in the measure of the amount of liquid contained in a
recipient [10]. However, the low accuracy of this type of sensor makes it unsuitable to measure volumes
as small as those under consideration here. Although lasers have also been proposed for this task, their
use is rather cumbersome because when a laser beam hits a liquid surface most of the beam power is
transmitted. Float devices equipped with mirrors have been proposed to address this problem [11], but
the ﬁnal cost of the sensor makes it prohibitive for our application.
Commercial ﬂowmeters are often used in industrial applications to measure the amount of ﬂuid ﬂow-
ing through a tube. These devices are designed to measure a continuous ﬂow of liquid, while UO is
usually a small erratic drip. Furthermore, the sensor would have to be disposed of because it would be
in direct contact with the urine, making it cost prohibitive.
To the best of our knowledge, only two devices have been proposed for automatically measuring
patient’sUO.Oneofthesedevices, Urinfo2000, wasdevelopedbytheIsraeli companyMedynamix[12].
This device is based on a sensor that counts the number of drops of urine produced by the patient, and
from this count estimates UO. The average error of the sensor when used to take hourly measurements
was 8% (±25 mL). The authors provide no information on its performance when used to take moreSensors 2010, 10 938
continuous measurements. Medynamix never marketed this device. At present, the company has been
bought by Flowsense, a construction services company that seems to have discontinued Medynamix’s
work on biosensors.
The second device was built by the authors of this article [13]. It is based on a sensor made up of
two different volume containers. Both containers are connected, and they are arranged so that the larger
containerdoes not startﬁlling untilthesmallercontaineris completelyfull. Both containers are equipped
with a ﬂoat which moves vertically along a pole. The ﬂoats allow us to detect when each container is
full. A microcontrollerdetectstheﬁllingofthecontainers, releases theircontentbyactivatingan actuator
when it is required, and triggers an alarm if therapeutic goals are not being met.
The smaller container, which has a volume of 18 mL, is intended to provide an early warning of low
UO. If the patient has oliguria, a precise and continuous monitoring of UO is needed. Thus, if the small
container does not ﬁll within the expected time, an alarm is triggered indicating a state of oliguria, and
when the small container ﬁlls it will be emptied. When the patient is producing a very small amount of
urine, the small container will be ﬁlled a few times a day; therefore, the actuator and the valve it opens
and closes will not be subjected to signiﬁcant stress. However, if the patient were producing normal
amounts of urine or, even worse, if he/she had polyuria—these patients may produce up to 1 L of urine
per hour—acontainerofsuch alowvolumewouldrequireitscontentto bereleased up to severalhundred
times per day. Carrying out several hundred operations per day can cause considerable stress both on
the release valve and on the actuator. The result would be an increase in price of an actuator and valve
capable of supporting this stress without breaking the sterility of the device.
To solve this problem, when the patient does not have oliguria—and thus the small container ﬁlls
within the expected time—the microcontroller does not releases the small sensor’s content when it gets
full, butitwaitsuntilbothcontainersarefull. Thesumofthevolumesofbothcontainersisapproximately
180 mL. Therefore, for a patient who has severe polyuria, the actuator will be triggered no more than a
few dozen times a day.
The device presented in [13] is capable of providing feedback on the patient’s UO with at least the
same measuring interval used when manually supervising this parameter—1 hour—and in most cases
within 20 or 30 min. However, when the intent is to use it in clinical studies that attempt to ﬁnd cor-
relations between UO patterns and the administration of drugs or the patients’ pathology evolution, this
device has several drawbacks. On the one hand, the device only measures the instants of time at which
urine production reaches certain values, but it provides no information on the rate of urine production
between two consecutive measurements. On the other hand, it is not easy to build a sterile prototype of
the custom sensor and actuator that are compliant with all laws applicable to a device that would be in
indirect contact with the patient’s bladder.
2.2. Design Constraints for the New Device
When designing the device presented in this paper, we strived to design a device that would measure
UO asaccurately as possible,withtheminimumacceptableaccuracy providedbytherequirementsofour
medical team. All components of the device that make contact with the urine would be easy to dispose
of and cheap. The device would have to be built with readily available components, to simplify the
prototype construction. Finally, it would be compliant with all the laws that apply to commercial urineSensors 2010, 10 939
meters, so the device could be approved by a Hospital Ethics Committee for the purpose of conducting
clinical studies in critical care patients.
A simple solution to building a law compliant urine meter capable of automatically recording and
supervising UO is to incorporate a commercial urine meter into the research device without breaking its
sterility. We evaluated two different approaches to achieve this. The ﬁrst one involved using a video
camera to take pictures of the commercial urine meter in order to calculate the amount of urine produced
from the images. The second approach required the use of a high-precision industrial scale. The ﬁrst al-
ternative requires greater computing power for processing the images, and relies on a careful positioning
of the urine meter in order to function properly. The problem with the careful positioning of the device
is aggravated by the fact that with this solution the healthcare staff would still have to open the graduated
container valve every hour, and possibly modify the position of the device while doing so. Furthermore,
a high precision scale can provide greater accuracy in the measurements. Thus, we opted for using
the scale.
3. The device
3.1. Measuring Urine Output: The Sensor
To buildourdeviceweused thehigh-precisionindustrialscalePGW 4502e, builtby AdamEquipment
Inc. It has an accuracy of 0.01 g and a maximum capacity of 4500 g. We also used the commercial
urine meter Unometer 500 built by Unomedical. The urine meter consists of two containers. One is
a graduated plastic container with 500 mL of capacity which is equipped with a top opening with a
ﬁlter that is used to equalize the internal and external pressures without risk of bacterial contamination.
The second container is a ﬂexible polymer plastic bag with 2000 mL of capacity. The containers are
connected by a rigid tube and a valve, which in our device is always open; thus the two containers can be
viewed as a single compartment. The Foley catheter connects to a polymer plastic, ﬂexible, transparent,
110 cm length tube that is connected to the graduated container of the Unometer 500.
Figure 2. Device design.
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We attached a metal structure built with Bosch proﬁles to the scale’s pan to hold the commercial
urine meter (see Figure 2). The graduated container of the Unometer 500 is equipped with two hooks,
one placed on each side of the container. We have used them to hang the device from the Bosch proﬁle
structure. Two screwless fasteners hold the input tube to the metal structure, and a third screwless
fastener ﬁxes the tube to a vertical pole. The purpose of the pole is to ensure that the input tube always
lies in such a way that it does not hinder the ﬂow of urine and it does not interfere with the operation
of the scale. To this end, any portion of the tube between the pole and the Bosch proﬁle structure must
form a slightly negative angle with the horizon, to ensure that urine ﬂows properly. However, at least in
a portion of the tube, the angle must be small enough to prevent the transmission of forces from the bed
of the patient towards the scale. An appropriate value for the angle formed by the tube and the horizon
would be at least 5o at every point and, in at least a portion of the tube, the angle must be less than 10o
to avoid force transmission.
Figure 3. Picture of the urine meter prototype.
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The PGW 4502escale is provided with a RS232 port. By sendinga command to this port it is possible
to obtain the scale reading. To avoid the need for wiring the scale to the PC that takes the readings, a
serial-port-to-Bluetooth adapter is used. This allows us to take readings from any PC equipped with a
Bluetooth interface. A picture of our prototype device can be seen in Figure 3.
3.2. Processing the Measures
A Java application installed on a PC receives the readings through Bluetooth. The PGW 4502e scale
can be conﬁgured to send measures only when the weight detected by the scale is stable. This feature
is highly effective at removing transient artifacts, like those which may be produced by the nursing staff
interacting with the commercial urine meter, or inadvertently touching the frame placed on top of the
scale’s pan. The drawback of this feature is that the acquisition rate of scale measurements can vary:
when this feature is enabled, the scale does not reply to the send measure command until the weight
measured is stable.
Despite this disadvantage, we decided to use this feature because it is highly effective in removing
artifacts. When the UO measure is not obtained at the expected time, cubic interpolation is used to
generate a measure at the desired instant. In the cubic interpolation, we use the reading that was not
taken at the desired instant, plus the three previous readings.
The acquisition sampling rate can be conﬁgured from the Java application itself, ranging from one
minute to an hour. If the application waits more than ﬁve minutes for the response to the send measure
command; i.e., the weight detected by the scale is not stable for more than ﬁve minutes, the program
generates an audible warning to alert the healthcare staff that the device is malfunctioning.
The Java application allows the healthcare staff to inspect a graph showing the patient’s UO in
milliliters per hour. Furthermore, the therapeutic goals for UO can be established using this program.
These therapeutic goals are represented with the aid of the Fuzzy Set Theory, a tool which has proved its
value for handling and representing experience-based heuristic knowledge, such as that commonly used
in the medical domain [14].
We shall introduce some basic concepts of the Fuzzy Set Theory which are the basis for our solution
to supervise therapeutic goals. Given a discourse universe R we deﬁne the concept of fuzzy value A by
means of a possibility distribution πA deﬁned over R [15]. Given a precise value x ∈ R, πA(x) ∈ [0,1]
represents the possibility of A being precisely x. A fuzzy number [16] is a normal and convex fuzzy
value. A fuzzy value A is normal if and only if ∃x ∈ R, πA(x) = 1. A is said to be convex if and only
if ∀ x, x′, x′′ ∈ R, x′ ∈ [x,x′′], πA(x′) ≥ min{πA(x),πA(x′′)}.
We obtain a fuzzy number A from a ﬂexible constraint given by a possibility distribution πA, which
deﬁnes a mapping from R to the real interval [0,1]. A fuzzy constraint can be induced by an item of
information such as “x has a high value”, where “high value” will be represented by πA=high. Given
a precise number x ∈ R, πA=high(x) ∈ [0,1] represents the possibility of A being precisely x; i.e., the
degree with which x fulﬁlls the constraint induced by “high value”.
Normality and convexity properties are satisﬁed by representing πA, for example, by means of a
trapezoidal representation. In this way, A = (α,β,γ,δ), α ≤ β ≤ γ ≤ δ, where [β,γ] represents the
core, core(A) = {x ∈ R| πA(x) = 1}, and ]α,δ[represents thesupport, supp(A) = {x ∈ R|πA(x) > 0}
(seeFigure4). WehaveoptedforthetrapezoidalrepresentationowingtoitscomputationalefﬁciencyandSensors 2010, 10 942
the intuitiveness of its semantics. Furthermore in possibility theory, rather than the precise assignment
of possibility degrees, what matters is the order of the possibility degrees attached to different values.
Figure 4. Trapezoidal possibility distribution representing the therapeutic goal for urine
output.
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We shall represent the therapeutic goals for UO by the trapezoidal possibility distribution πU. The
beginning of the support of the distribution is a value such that if the patient is producing that amount of
urine, or less, the patient clearly has oliguria. The beginning of the core is a value such that if the patient
is producing that amount of urine, or more, the patient clearly does not have oliguria. The end of the core
is a value such that if the patient is producing that amount of urine, or less, the patient clearly does not
have polyuria. The end of the support is a value such that if the patient is producing that amount of urine,
or more, the patient clearly has polyuria. The beginning and end of the core of the distribution limit
the interval within which ideal values of UO lie; i.e., the interval where the patient clearly has neither
oliguria nor polyuria (see Figure 4).
Given the deﬁnition we use for the beginning and end of the support and core of the distribution, the
acquisition of the supervision criteria is simple and easily understood by the healthcare staff. On the
other hand, by representing therapeutic goals with a possibility distribution we avoid errors produced by
employing some arbitrary crisp limits when classifying the state of the patient in “oliguria”, “ideal state”
and “polyuria”.
Physicians are accustomed to expressing the therapeutic goals for UO in milliliters per kilogram of
patient body mass per hour (mL/kg  h). Our tool allows them to specify the therapeutic goals—πU—in
these units. In order to be able to convert the information provided by the scale to mL/kg   h, we also
need physiciansto indicatethe weight of the patient—P—(seeFigure 5). Let us supposethat thereading
provided by the scale at the instant ti−1, i ≥ 1, is Wi−1; and that the following reading, taken at ti, is
Wi. The density of urine is between 1.005 and 1.035 g/mL, and has an average value of approximately
1.020 g/mL. Therefore, the amount of urine produced during the interval [ti,ti+1], measured in mL/kg  
h., will be:
ui =
Wi − Wi−1
(ti − ti−1)   1.020   P
(1)Sensors 2010, 10 943
where P is the patient’s weight in kilograms, Wi − Wi−1 must be expressed in g, and ti − ti−1 must be
expressed in hours.
Figure 5. Main screen of the Java application showing urine output and the window that
allows healthcare staff to set therapeutic goals.
πU can be interpreted as a computational projection of the piece of clinical knowledge “adequate
UO”. Thus, the degree to which the therapeutic goals established for the patient are being met is given
by πU(ui). If πU(ui) = 0, either UO is less than the minimum acceptable value—the patient clearly
has oliguria or anuria, or it is greater than the maximum acceptable—the patient clearly has polyuria. If
πU(ui) = 1, UO is within the range of ideal values. The closer πU(ui) is to 1, the closer the amount of
urine produced by the patient is to the ideal value, and the closer πU(ui) is to 0, the closer the patient is
to oliguria or polyuria.
πU(ui) is useful information in assessing the patient’s state. However, a possibility degree between 0
and 1 is not the best representation of information that has to be presented to healthcare staff. A color
code used when drawing the graph of UO is a much more suitable solution, and it has been used suc-
cessfully by the authors on similar problems [1, 17]. Red represents the null compatibility—the patient
clearly has oliguria or polyuria–, followed by orange, pink, yellow, green and black, which representsSensors 2010, 10 944
the total compatibility—the UO lies within the range of ideal values. In this way, the UO graph pro-
vides instantaneous visual feedback on the patient’s state (see Figure 5).
Besides providing visual feedback, a monitoring device should have audible warnings to alert the
healthcare staff about serious deviations from therapeutic goals. The application produces an audible
warning until it is turned off by the healthcare staff whenever πU(ui) = 0. It also produces a different
audible warning when the scale does not respond to the send measure command within ﬁve minutes
to warn of a malfunction in the device. Finally, the program can be conﬁgured to emit a third type of
audible warning when the total urine production of the patient reaches a certain threshold. The purpose
of this alarm is to alert healthcare staff when it is time to empty the plastic bag of the commercial urine
meter. Before emptying the bag, the healthcare staff must click a button to indicate that this action is
going to be performed. When the button is clicked, the program takes one last measure from the scale,
stops monitoring, and informs the healthcare staff that the bag can be emptied. Once this process has
been completed, the button must be clicked again to resume monitoring.
3.3. Accuracy of the Sensor
The main source of error in the measures is the approximate value used for urine density in Equation
1. This value varies between 1.005 and 1.035 g/mL; thus by using the average value of 1.020 g/mL the
maximumerror inthemeasurements willbeapproximately1.5%. TheJavaapplicationallowshealthcare
staff to modify the urine density value if the exact value is known, although this is seldom the case.
The high-precision industrial scale we used has a maximum error ensured by the manufacturer of
±0.01 g. Thus, this error is negligible when compared to the error in estimating urine density. However,
this error can only be applied to measurements in which an object is placed on the scales’ pan and the
measure is immediately taken. When the scale is used to record continuous measurements over time,
as in our application, room temperature variations can affect the scale and produce an additional source
of noise.
To characterize this noise we performed several tests where the readings of the scale were recorded
over 6 days, taking one reading every ﬁve minutes. The weight placed on the scale’s pan remained
constant throughout each day. Therefore, deviations from the initial weight correspond to errors in the
measure. Figure 6 shows the scale readings taken during the six days. They are represented as six
different time series, each one corresponding with the readings taken from 00:00:00 to 23:59:59 of every
day. All measures started at 00:00:00; thus the value of all the time series in this instant is 0 g.
The public building where the measurements took place opens its doors at 07:00. Air conditioning is
switched on at 07:30. The air conditioning is switched off at 18:00. The operation of air conditioning,
in all probability, causes the increase in scale readings between these hours. The continued decrease
that begins shortly after 18:00 very likely corresponds with the return to the initial state after the air
conditioning has been switched off. During night hours, readings are quite stable.
In a critical care unit, room temperature is controlled by air conditioning 24 hours a day, usually
remainingbetween20◦ and24◦ C.Duringourexperiments,thevariationsinroomtemperaturewereupto
10◦ C. Therefore, we can conclude that, for our application, the situation shown in Figure 6 corresponds
with a worst case scenario of room temperature variation. In our tests, the maximum hourly variation on
the scale readings was slightly over 0.3 g. This leads us to estimate that the maximum error produced bySensors 2010, 10 945
variations in room temperature when the device is employed in a critical care unit will always be within
±0.4 g ≃ ±0.4 mL per hour.
Figure 6. Noise caused by variations in room temperature
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A third potential source of noise in the measures is caused by the characteristics of our experimental
setup. A section of the plastic input tube of the commercial urine meter hangs between the frame located
on top of the scale and the pole (see Figure 2). When this tube is placed by the healthcare staff, it will
not be in a stable state, but will slowly change its position until a stable state is reached. The changes
in the tube position are imperceptible to the human eye and they are subtle enough to be ignored by the
stability ﬁlter of the scale, but they do inﬂuence the values registered by the scale.
A ﬂexible tube hanging between two ﬁxed points at the mercy of gravity changes its position at an
exponentially decreasing rate until it reaches stability. The longer the tube section located between two
ﬁxed points is, the faster the tube reaches its stable state. The tube’s movement can cause more of the
tube’s weight to fall over the scale or over the pole (see Figure 2). In the ﬁrst case, the scale should
register a weight increase, while in the second it should register a weight decrease.
To characterize this error we carried out a series of experiments in which we began to record the
scale’s measurements just after the commercial urine meter was set up. The measures were taken every
10 seconds, for a total of ﬁveminutes. Experiments were conducted for different lengths of the section of
the tube located between the frame placed on top of the scale and the pole. For each length, six different
experiments were carried out. Results are shown in Figure 7.
For a section length of 10 cm, the error during the ﬁrst ﬁve minutes can reach ±2 g, but as the
length of the section of the tube increases, the magnitude of the errors decreases. For a section length of
35 cm, the error during the ﬁrst ﬁve minutes remains within ±0.4 g, We can also see how, for every
section length, the error of each new reading decreases exponentially. For all section lengths, except
for 10 cm, the tube is stable after ﬁve minutes. Most of the drop of the tube occurs during the ﬁrst
minute, and after the ﬁrst 150 seconds the tube can be considered to be in a stable state, except for the
10 cm tests.Sensors 2010, 10 946
Figure 7. Behavior of the device during the ﬁve minutes just after the commercial urine
meter was set up. Different tube lengths are shown.
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Based on these experiments, the following guidelines for using the device were developed. The
minimum length of the hanging tube section must be 20 cm, although longer lengths should be used
if possible. At least two and half minutes must pass from the set up of the commercial urine meter
until the time at which the recording is started. Under these conditions, we estimate that the error
that the movement of the tube may cause during the ﬁrst ﬁve minutes of recording should be under
±0.2 g ≃ ±0.2 mL.
Waiting at least two and half minutes before the start of the monitoring should not be a major problem
given that before the monitoring can start, it is necessary to perform the urethral catheterization. This
process requires approximately ﬁve minutes. If the healthcare staff set ups our device just before starting
the catheterization, the tube will be stable when they have ﬁnished the procedure.
In summary, we estimate that the maximum error of our device when measuring hourly UO is ±1.5%
of the patient’s UO, plus ±0.4 mL caused by the room temperature variation. For the ﬁrst hour ofSensors 2010, 10 947
monitoring, we must add ±0.2 mL caused by the input tube movement. The patient that produces just
under 40 mL of urine during the ﬁrst hour of monitoring provides the worst case scenario according
to the constraints imposed by our medical team. In this case, the maximum error of our device is
±(1.5% 40 mL + 0.4 mL + 0.2 mL) ≃ ±1.2 mL. The maximum error that our medical team speciﬁed
for this scenario was ±3 mL.
4. Results
A series of tests to verify the proper operation of the prototype device have been performed. In the
tests a saline solution with similar properties to urine was used. This liquid was stored in a container
placed at a higher level than the sensor, and a dropper was used to regulate the ﬂow of ﬂuid from this
container to the sensor (see Figure 3). In the tests the amount of ﬂuid sent to the sensor was carefully
measured with a graduated cylinder in order to verify that the amount of urine detected by the Java
application was accurate.
A stress test in which the system worked continuously for seven days was also conducted. After the
seven days, it was found that both the scale as well as the Java application were still operating correctly
and that the amount of urine detected by the application was correct.
After this initial validation, the device is been used in a research unit associated with the University
Hospital of Getafe in Madrid, Spain. In this research unit, a series of experiments aimed at the study of
sepsis in an animal model (pigs) are being conducted. Their goal is to gain a better understanding of the
pathophysiological mechanisms underlying systemic and renal hemodynamics during sepsis. Sepsis is a
serious medical condition characterized by a systemic inﬂammatory state that has developed in response
to an infection and affects the patient´s entire body. Patients affected by this pathology are treated in an
intensive care unit, and often require artiﬁcial ventilation and dialysis to support the functioning of the
lungs and kidneys, respectively [18].
In these experiments, sepsis is induced by the administration of Escherichia coli –E. coli– bacteria.
Animals are anesthetized and mechanically ventilated via tracheostomy. The following parameters are
monitored invasively during the experiment: blood pressure, pulmonary arterial pressure (measured by
a Swan-Ganz catheter), renal artery ﬂow (measured by a Doppler sensor) and central ﬂow (measured by
a laser-Doppler probe). UO is continuously monitored by our device.
The fact that one of the goals of these experiments is to study renal hemodynamicsmakes the scenario
ideal for testing our device [19]. Furthermore, these experiments allow us to reﬁne our device. For
example, after operating the device, physicians saw a need for the ability to place annotations over the
temporal axis on the graph of UO. This would simplify the task of relating UO patterns with external
events—represented by the annotations—such as the supply of a drug, the supply of a volume overload
or any other therapeutic action. The feature has already been added to the Java application. If the initial
animal trial is successful, before the end of this year we will start using our device in clinical studies
with human patients admitted to the burn unit of the University Hospital of Getafe.Sensors 2010, 10 948
5. Discussion
The monitoring interval currently employed for UO—once every hour—establishes a compromise
between avoiding risk states for the patient and not placing an excessive burden on the nursing staff.
An automatic system, as the one described in this article, decreases the workload associated with mon-
itoring UO and permits supervision to be carried out on a virtually continuous basis. Furthermore, the
automation of the supervision of this parameter has the additional beneﬁt of preventing human errors in
this task.
To the best of our knowledge, no clinical studies have been conducted about the patterns of UO
production where the monitoring interval was less than one hour. It may be the case that by carrying
out the supervision of UO on a more continuous basis, healthcare staff can identify deviations from
therapeutic goals at earlier stages, allowing the patient´s therapy to be modiﬁed more promptly, leading
him/her more quickly to the desired state. A device for measuring UO on a virtually continuous basis
with high accuracy, as the one presented in this article, is ideal for trying to ﬁnd subtle correlations
between UO patterns and drug therapy and/or the evolution of the patients’ pathology. Thus, it is ideal
for carrying out studies where UO measures are taken more often than at present in critical care units.
Such clinical studies will also help deﬁne the optimum monitoring interval for UO, and determine the
level of accuracy required for this task. In all likelihood, the accuracy of the device presented here is
higher than required, and it is probably not necessary to monitor this parameter as continuously as our
device permits. While this does not hinder the realization of clinical studies, it is a disadvantage for a
commercial device designed to automate the monitoring and supervision of UO. In this situation, more
accuracy than necessary and a higher acquisition rate than required would needlessly increase the price
of the commercial device.
Currently, every hour a nurse must visit each of the patients’s beds of the critical care unit to manually
record UO, must operate the valve that releases urine from the graduated container to the plastic bag,
and must check if the plastic bag needs to be emptied. These tasks must be performed for each patient
admitted to the critical care unit 24 times a day, 365 days a year. The solution presented in this paper
completely eliminates these tasks, given that it not only automates the monitoring of UO, but it also
can alert the nursing staff when it is necessary to empty the plastic bag. We estimate that all the tasks
associated with UO monitoring for every 15 critical care unit patients during 24 hours require a time
equivalent to one nurse´s workshift. Thus, even a partial automation of these tasks can yield economic
savings for the institutions that provide healthcare services.
The maximum hourly measurement error of our device is ±1.5% of the patient’s UO during the hour
(urine density variations) plus ±0.4 mL (room temperature variations). Currently, the measurement
of urine is carried out visually. In the Unometer 500, for example, separations between the coarser
measurement divisions in the 500 mL graduated container correspond with 20 mL; i.e., a 4% error.
However, this highly optimistic estimation of the error assumes that the visual measurements are taken
in ideal conditions; i.e., the graduated container is not tilted in any direction and the nurse’s eyes are
in the same horizontal plane as the graduated container. In [12], a study on the accuracy of visual
measurements of UO was performed. According to this study, in practice these errors are about 26%.
In critical care units measures are not taken under ideal conditions. Besides this, two additional factorsSensors 2010, 10 949
contributed to this high error. Sometimes the nurses did not properly close the graduated container valve;
thus part of the urine produced during one hour leaked into the plastic bag and was not measured. Then,
some patients had polyuria and they produced more than 500 mL of urine per hour. When this happens,
the urine overﬂows from the graduated container and falls directly into the plastic bag, without being
measured. The occurrence of these types of errors in critical care units increases the value of a device
that automates the monitoring of UO.
Compared with the device the authors previously developed for monitoring UO [13], the one pre-
sented in this work has higherprecision and is capable ofmeasuring UO continuously,whilethe previous
device was only capable of measuring the time that the patient required to produce certain amounts of
urine. Furthermore, the process of building a sterile version of the device that can be used in tests with
humans is much less complicated.
The device developed by Medynamix [12] automates the recording of UO, but it cannot supervise any
therapeutic goals. Its readings are not transmitted to a PC, and it does not alert the health care staff when
it is necessary to empty the urine meter’s plastic bag. Therefore, in practice the healthcare staff would
need to check each patientevery hour. According to its designers, the mean error ofthedevicewhen used
to measure hourly UO is 8%. This error does not meet the requirements speciﬁed by our medical team.
In defense of Medynamix’s device, these criteria originate from an informed opinion of an experienced
medical team rather than a consensus. Furthermore, when they provided these criteria, they had in mind
a device aimed at conducting clinical studies about subtle UO production patterns, and not a device that
it is just intended to automate the hourly monitoring of UO, as is the case of Medynamix’sdevice. It may
well be that the accuracy of their device is indeed enough to properly measure hourly UO. However, this
lower accuracy does make their device less appropriate than ours to conduct clinical studies.
6. Conclusions and Future Work
We havebuiltadevicecapableofautomaticallymonitoringand supervisingtheurineoutputof critical
care patients. It is based on an industrial scale that provides a high-precision measurement of the weight
of a commercial urine meter. To ensure the proper functioning of the urine meter and the scale, we
have designed a frame that prevents force transmission from the patient’s bed and ensures that the urine
ﬂows properly. Scale readings are transmitted via Bluetooth to a Java application that runs on a PC. This
application displays the patient’s urine output throughout his/her stay in the critical care unit, and alerts
the healthcare staff of any deviation that occurs with respect to the established therapeutic goals.
Therapeutic goals are represented by a trapezoidal possibility distribution. The use of fuzzy logic for
this task prevents mistakes when triggering alarms for patients which lie on the borderline between the
ideal state and a pathological state—oliuguria or polyuria. When displaying the patient’s urine output,
we use a color code that represents different degrees of deviation from therapeutic goals. Thus, our
application provides an instantaneous visual feedback about the status of the patient´s urine output.
The main source of error in our device is produced by using an average urine density value of
1.020 g/mL to transform the scale measures (grams) to milliliters. This introduces an error of up to
1.5% in the measurements. Other sources of error are changes in room temperature, which affect the
scale readings, and the initial transient state during which the position of the input tube of the commer-
cial urine meter varies slightly. To characterize these errors, we have conducted a series of experiments.Sensors 2010, 10 950
As a result, under normal operating conditions in a critical care unit, the maximum error in the measures
is ±1.5% of the patient’s UO (urine density variations) plus ±0.4 mL (room temperature variations),
plus ±0.2 mL for the ﬁrst hour (tube movements). This error is considerably smaller than the error com-
mitted when taking visual measurements, and those committed by other devices proposed to measure
urine output automatically [12, 13].
Currently, our device is being used in tests performed on animals in a research unit associated with
the University Hospital of Getafe. As future work, we intend to use our device in the burn unit of this
hospital, where we expect to conduct a series of clinical studies based on a more continuous and accurate
monitoring of urine output throughout the stay of patients in a burn unit. The aim of these studies is to
ﬁnd relationships between urine output patterns and therapeutic actions, such as the administration of
drugs, or the patients’ evolution throughout his/her pathology. The high accuracy and acquisition rate of
our device make it ideal for carrying out such studies.
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